ask="6.79"
ask_size="600"
average_daily_volume="2630"
bid="6.40"
bid_size="100"
book_value="3.48"
change="+0.02"
change_from_200_day_moving_average="-1.38"
change_from_50_day_moving_average="-0.30"
change_from_52_week_high="-13.23"
change_From_52_week_low="0.12"
change_in_percent="+0.31%"
close="6.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.29"
ebitda="-22.23M"
eps_estimate_current_year="-1.97"
eps_estimate_next_quarter="-0.98"
eps_estimate_next_year="-4.05"
ex_dividend_date="N/A"
float_shares="3374000"
high="6.80"
high_52_weeks="19.75"
last_trade_date="3/14/2017"
last_trade_price="6.52"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.43"
low_52_weeks="6.40"
market_capitalization="76.78M"
moving_average_200_day="7.90"
moving_average_50_day="6.82"
name="Akari Therapeutics Plc"
notes="N/A"
one_year_target_price="19.00"
open="6.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.48%"
percent_change_from_50_day_moving_average="-4.41%"
percent_change_from_52_week_high="-66.99%"
percent_change_from_52_week_low="+1.87%"
previous_close="6.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.87"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11776000"
short_ratio="12.64"
stock_exchange="NCM"
symbol="AKTX"
volume="2929"
weeks_range_52="6.40 - 19.75"
